You are here:
| Reference : L'hormonothérapie de substitution transdermique: une mode ou un avantage? |
| Scientific journals : Article | |||
| Human health sciences : Reproductive medicine (gynecology, andrology, obstetrics) | |||
| http://hdl.handle.net/2268/82883 | |||
| L'hormonothérapie de substitution transdermique: une mode ou un avantage? | |
| French | |
| [en] Transdermal Replacement Hormone Therapy: A Trend or an Advantage? | |
Foidart, Jean-Michel  [Université de Liège - ULg > Département des sciences cliniques > Gynécologie - Obstétrique >] | |
| Desreux, Joëlle [Centre Hospitalier Universitaire de Liège - CHU > > Sénologie >] | |
| Pintiaux, Axelle [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique CHR >] | |
| Moreau, Liesbet [ > > ] | |
| Apr-1998 | |
| Revue Médicale de Liège | |
| Hopital de Baviere | |
| 53 | |
| 4 | |
| 208-11 | |
| National | |
| 0370-629X | |
| Liège | |
| Belgique | |
| [en] This review describes the clinical usefulness of transdermal hormone replacement therapy. This route of administration is particularly important in women with hypertriglyceridemia, in hypertensive postmenopausal women, in women who smoke or have an increased risk of biliary or liver disorder, for those who display a reduced glucose tolerance or in women who are at risk of thrombotic disorders. The avoidance of the "first passage effect" is ensured by the transdermal application of estrogen and probably explains the superiority of this route of steroid administration. | |
| http://hdl.handle.net/2268/82883 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.
